| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $1.19B | +12.8% |
| Cost of Revenue | $1.12B | +11.9% |
| Gross Profit | $73.8M | +28.6% |
| R&D Expense | $100K | -66.7% |
| SG&A Expense | $65.7M | +15.9% |
| Operating Income | $6.0M | +159.9% |
| Interest Expense | $1.7M | +111.3% |
| Pre-tax Income | -$2.8M | -137.2% |
| Income Tax | $3.3M |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | +9.3% |
| Accounts Receivable | $59.0M | -25.2% |
| Inventory | $38.8M | -4.7% |
| Current Assets | $125.7M | -17.7% |
| Total Assets | $385.7M | -13.4% |
| Current Liabilities | $102.0M | -11.1% |
| Long-term Debt | $4.4M | -19.9% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.2M | +270.1% |
| Capital Expenditures | $9.8M | -14.6% |
| Investing Cash Flow | $8.7M | +192.7% |
| Financing Cash Flow | -$58.6M | -984.2% |
| Free Cash Flow | $40.5M | +1796.2% |
| -69.7% |
| Net Income | -$6.2M | +47.1% |
| EPS (Basic) | -$0.35 | +47.8% |
| EPS (Diluted) | -$0.35 | +47.8% |
| Stockholders' Equity |
| $223.4M |
| -1.5% |